Roberts Arthur G, Bowman Michael K, Kramer David M
Institute of Biological Chemistry, Washington State University, 289 Clark Hall, Pullman, Washington 99164-6340, USA.
Biochemistry. 2002 Mar 26;41(12):4070-9. doi: 10.1021/bi015996k.
Many current models of the Q cycle for the cytochrome (cyt) b6f and the cyt bc1 complexes incorporate 'Rieske' iron-sulfur protein (ISP) domain movements to gate electron transfer and to ensure high yields of proton shuttling. It was previously proposed that copper ions, which bind at a site distant from the quinol oxidase (Q(o)) site, inhibit plastoquinol (PQH2) binding by restraining the hydrophilic head domain of the ISP [Rao B. K., S., Tyryshkin, A. M., Roberts, A. G., Bowman, M. K., and Kramer, D. M. (1999) Biochemistry 38, 3285-3296]. The present work presents evidence that this is indeed the case for both copper ions and Zn2+, which appear to inhibit by similar mechanisms. Electron paramagnetic resonance (EPR) spectra show that Cu2+ and Zn2+ binding to the cyt b6f complex displaces the Q(o) site inhibitor 2,5-dibromo-3-methyl-6-isopropylbenzoquinone (DBMIB). At high concentrations, both DBMIB and Cu2+ or Zn2+ can bind simultaneously, altering the Rieske 2Fe2S cluster and Cu2+ EPR spectra, suggesting perturbations in their respective binding sites. Both Zn2+ and Cu1+ altered the orientations of the Rieske 2Fe2S cluster with respect to the membrane plane, but had no effect on that of the cyt b6 hemes. Cu2+ was found to change the orientation of the cyt f heme plane, consistent with binding on the cyt f protein. Within conservative constraints, the data suggest that the ISP is shifted into a position intermediate between the ISP(C) position, when the Q(o) site is unoccupied, and the ISP(B) position, when the Q(o) site is occupied by inhibitors such as DBMIB or stigmatellin. These results support the role of ISP domain movements in Q(o) site catalysis.
目前许多关于细胞色素(cyt)b6f和cyt bc1复合物的Q循环模型都纳入了“里氏”铁硫蛋白(ISP)结构域的移动,以控制电子转移并确保高质子穿梭产率。此前有人提出,结合在远离醌醇氧化酶(Q(o))位点的一个位点上的铜离子,通过限制ISP的亲水头结构域来抑制质体醌(PQH2)的结合[Rao B. K., S., Tyryshkin, A. M., Roberts, A. G., Bowman, M. K., and Kramer, D. M. (1999) Biochemistry 38, 3285 - 3296]。目前的研究工作提供了证据,表明铜离子和Zn2+确实都是如此,它们似乎通过类似的机制产生抑制作用。电子顺磁共振(EPR)光谱表明,Cu2+和Zn2+与cyt b6f复合物的结合会取代Q(o)位点抑制剂2,5 - 二溴 - 3 - 甲基 - 6 - 异丙基苯醌(DBMIB)。在高浓度下,DBMIB和Cu2+或Zn2+都能同时结合,改变里氏2Fe2S簇和Cu2+的EPR光谱,表明它们各自结合位点受到了扰动。Zn2+和Cu1+都改变了里氏2Fe2S簇相对于膜平面的方向,但对cyt b血红素的方向没有影响。发现Cu2+会改变cyt f血红素平面的方向,这与它在cyt f蛋白上的结合情况一致。在保守的限制范围内,数据表明ISP会移动到一个中间位置,该位置介于Q(o)位点未被占据时的ISP(C)位置和Q(o)位点被DBMIB或柱晶白霉素等抑制剂占据时的ISP(B)位置之间。这些结果支持了ISP结构域移动在Q(o)位点催化中的作用。